SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-039734
Filing Date
2019-07-01
Accepted
2019-07-01 16:34:48
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4155
  Complete submission text file 0001209191-19-039734.txt   5684
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Van Wart Harold (Reporting) CIK: 0001580680 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 19933661